Experience of EU countries on ethical aspects of patenting biotechnologies in the field of medicine and pharmacy

Keywords: patenting, ethics, biotechnological inventions, medicine, pharmaceuticals,health
 The progress ofmodern achievements poses new ethical and social challenges to society.Research using biotechnology in medicine pharmacy leads more in-depthknowledge of diseases. With the help biotechnology, it becomes possible treatpreviously incurable It is worth noting that today with possibility ofusing developments, scientific community a very short timewas able successfully invent vaccines against COVID-19.During clinical trials, safety study subjects should be unneglected for therapid introduction product market. Ethics innovation modern societyalways go hand hand, especially field health care. worldwidespread COVID-19 underscores importance maintaining balance betweenethics intellectual property rights when human lives are mortal danger.Society concerned about ethics patenting life, namely, ofpatenting genes, cell lines tissues. Directive states humanbody cannot invented at certain stages its formation development, includinggerm cells, as well simple discovery one components, including sequenceor partial sequence gene.Patents relate gene particularly critically examined ethically.Ethics, morality, law interrelated components extremely importantfor society accept invention. EU patent based on principles. Thus, theadoption was envisaged development economy, abilityto regulate controversial issues regarding inventionsby criteria morality harmonize legislation.Owners who run institutions (organizations) must protect results ofresearch, obtaining patents most effective way. After all, long-term researchand products or processes require significant financial costs. intellectualproperty protected by patent, inventions.